Publication:
Bacterial Contamination Risk of Propofol Vials Used in Daily Anesthesia Practice and Evaluation of Antibacterial Effect of Lidocaine

dc.authorscopusid22942100300
dc.authorscopusid26028752200
dc.authorscopusid23004277500
dc.authorscopusid56071261100
dc.authorscopusid24921986700
dc.authorscopusid36886143600
dc.authorscopusid36886143600
dc.contributor.authorÜlger, F.
dc.contributor.authorDilek, A.
dc.contributor.authorDarka, Ö.
dc.contributor.authorYilmaz, M.Z.
dc.contributor.authorSarikaya, H.
dc.contributor.authorEsen, Ş.
dc.contributor.authorKarakaya, D.
dc.date.accessioned2025-12-10T21:22:00Z
dc.date.issued2008
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Ülger] Fatma Esra Bahadır, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Dilek] Ahmet, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Darka] Özge, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yilmaz] Mehmet Ziya, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Sarikaya] Hanife, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Esen] Şaban,; [Karakaya] Deniz, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractObjective: This study was performed to examine the bacterial contamination risk of propofol vials that are used for routine anesthesia practice and the antimicrobial effects of lidocaine which is added for prevention of injection pain in the operating theatres. Method: The samples were divided into two groups as propofol (Group P, n =55) or propofol plus 5 mL lidocaine 2 % (Group PL, n =54). Vials were opened early in the morning and used for a number of patients in routine anesthesia practice. The last used vials of the day were left in the room temperature for 24 hours on the following day. One hundred nine Propofol vials were collected and cultured samples were drawn into an automated aerobic hemoculture tube. Each culture tube was observed for microbial growth for fifteen days. Results: There was no bacterial contamination in all groups. All hemoculture tubes were observed for early and late bacterial growth, yielding no positive result. Conclusion: In our study, vials were kept at room temperature for 24 hours and no bacterial contamination was observed in any of the vials with or without lidocaine. Therefore, we cannot comment on the effect of lidocaine on bacterial contamination rate.en_US
dc.identifier.endpage182en_US
dc.identifier.issn1300-0578
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-60149099360
dc.identifier.scopusqualityQ4
dc.identifier.startpage179en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/34658
dc.identifier.volume16en_US
dc.identifier.wosqualityN/A
dc.language.isotren_US
dc.relation.ispartofAnestezi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDrug Contaminationen_US
dc.subjectLidocaineen_US
dc.subjectPropofolen_US
dc.titleBacterial Contamination Risk of Propofol Vials Used in Daily Anesthesia Practice and Evaluation of Antibacterial Effect of Lidocaineen_US
dc.title.alternativeGünlük Anestezi Pratiğinde Kullanılan Propofol Flakonlarının Bakteriyel Kontaminasyon Riski ve Lidokainin Antibakteriyel Etkinliğinin Değerlendirilmesien_US
dc.typeArticleen_US
dspace.entity.typePublication

Files